Horvat, T. Z., Adel, N. G., Dang, T., Momtaz, P., Postow, M. A., Callahan, M. K., . . . Chapman, P. B. (2015). Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. Journal of clinical oncology, 33(28), 3193. https://doi.org/10.1200/JCO.2015.60.8448
Citace podle Chicago (17th ed.)Horvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center." Journal of Clinical Oncology 33, no. 28 (2015): 3193. https://doi.org/10.1200/JCO.2015.60.8448.
Citace podle MLA (9th ed.)Horvat, Troy Z., et al. "Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center." Journal of Clinical Oncology, vol. 33, no. 28, 2015, p. 3193, https://doi.org/10.1200/JCO.2015.60.8448.